Pediatric Healthcare Industry Forecast and Size Analysis 2019-2025
Global Pediatric Healthcare Industry was valued at USD 123.7 Billion in the year 2017. Global Pediatric Healthcare Industry is further estimated to grow at a CAGR of 3.8% from 2019 to reach USD 166.96 Billion by the year 2025. The North America region holds the highest Industry share in 2017 and the Asia Pacific is considered as the fastest growing Industry in the forecasted period. At a country level, US, China and the U.S. are projected to grow strongly in the coming years due to increasing density of population. Major market players in Pediatric Healthcare Industry are Pfizer Inc., GlaxoSmithKline plc., Merck & Co. Inc, AstraZeneca plc., Boehringer Ingelheim GmbH, Gilead Sciences Inc., Sanofi S.A., Pediapharm Inc., Novartis AG, Eisai Co. Ltd., Mylan N.V., and brief overview of 9 companies is also provided in the report. Rising research and development expenses are catering to changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
Request Sample Copy of this Market Research Report @ https://www.alexareports.com/report-sample/9222
SWOT Analysis of Pediatric Healthcare Industry: Strength: Changes in lifestyle Rising awareness towards pediatric disorders Weakness: High cost